Record $48 billion deal seals sale of Tylenol maker
Johnson & Johnson has completed the sale of its consumer health business, including well-known brands like Tylenol and Neutrogena, to a consortium led by Carlyle Group for a historic $48 billion. This transaction, the largest in the healthcare sector this year, follows a tumultuous period marked by political and legal challenges. The deal, announced in…